Q4 2023 13F Holders as of 31 Dec 2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
52.4M
-
Number of holders
-
3
-
Total 13F shares, excl. options
-
66.4K
-
Shares change
-
+11.4K
-
Total reported value, excl. options
-
$285K
-
Value change
-
+$48.8K
-
Number of buys
-
1
-
Price
-
$4.27
Significant Holders of 2seventy bio, Inc. - Common Stock (TSVT) as of Q4 2023
3 filings reported holding TSVT - 2seventy bio, Inc. - Common Stock as of Q4 2023.
2seventy bio, Inc. - Common Stock (TSVT) has 3 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 66.4K shares
of 52.4M outstanding shares and own 0.13% of the company stock.
Largest 10 shareholders include Kynam Capital Management, LP (5.95M shares), MORGAN STANLEY (4.84M shares), GOLDMAN SACHS GROUP INC (4.51M shares), VANGUARD GROUP INC (3.99M shares), BlackRock Inc. (3.91M shares), BAKER BROS. ADVISORS LP (2.5M shares), MILLENNIUM MANAGEMENT LLC (2.34M shares), Madison Avenue Partners, LP (1.75M shares), Engine Capital Management, LP (1.49M shares), and DAFNA Capital Management LLC (1.45M shares).
This table shows the top 3 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.